Mobiflex (Indometacin)

Indometacin, the active ingredient in Mobiflex, is a non‑steroidal anti‑inflammatory drug (NSAID) presented as a topical formulation for external use. It is employed to relieve pain and reduce inflammation associated with musculoskeletal conditions such as arthritis and soft‑tissue injuries.

GNH USA supplies Mobiflex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin is used to manage pain and inflammation in several musculoskeletal and inflammatory conditions. - Arthritis: alleviates joint pain and swelling in rheumatoid and osteoarthritis. - Musculoskeletal pain: reduces discomfort from sprains, strains and overuse injuries. - Acute inflammation: diminishes localized inflammatory responses after trauma or surgery. - Tendinitis: eases pain and improves function in inflamed tendons.

Topical indometacin may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation: redness, itching or burning at the application site. - Dryness: localized skin dryness or flaking. - Pruritus: mild itching sensation. - Erythema: mild redness of the skin. - Contact dermatitis: allergic skin reaction in sensitive individuals.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic NSAID effects: gastrointestinal ulceration or bleeding. - Renal impairment: reduced kidney function with extensive use. - Hepatotoxicity: liver enzyme elevations. - Hypersensitivity: anaphylaxis or severe allergic response.

When using Mobiflex, consider the following safety measures. - Avoid broken skin: do not apply to open wounds or damaged skin. - Limit exposure: use only the prescribed area and duration. - Monitor for reactions: discontinue if severe skin irritation or systemic symptoms develop. - Caution with other NSAIDs: avoid concurrent systemic NSAID therapy to reduce risk of adverse effects. - Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. - Store at room temperature: keep below 25°C, in the original packaging, protected from moisture and direct sunlight.

Indometacin may interact with several drug classes, affecting safety or efficacy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Corticosteroids: amplified risk of ulceration and bleeding.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may enhance renal adverse effects. - Lithium: increased lithium levels leading to toxicity. - Methotrexate: reduced clearance, raising toxicity risk.